A whole new world

October 28, 2011 – 9:44 AM | By Amanda Pedersen | No comments yet

Five years ago this month my byline began appearing on the pages of Medical Device Daily. When I first joined the MDD staff in October 2006 I knew very little about this industry. It was like moving to a new country where the language, culture, and rules were completely foreign to me.

I was concerned, at first, that my lack of a medical or scientific background would hinder my ability to cover the space adequately. But I learned quickly and before I knew it I was well-versed on the differences between a drug-eluting stent and its bare-metal cousin, the pathway to commercialization via a 510(k) clearance and a pre-market application approval, and I knew that Johnson & Johnson had recently lost a fierce bidding war with rival Boston Scientific over stent maker Guidant – a deal J&J must, to this day, be thanking its lucky stars that it lost.

Without a doubt, reporting on the medical device industry has broadened my horizons as both a journalist and a healthcare consumer. Being a part of the med-tech universe over the past five years has changed me for the better, I believe. The world also has changed considerably in that time frame – for better or for worse, I’m not sure. Healthcare reform, comparative effectiveness, the device tax, CMS reimbursement, and a possible overhaul of the FDA’s 510(k) process are just a few of the hot-button topics that have soaked up much of our attention in recent years.

To illustrate some of the ways med-tech has changed during my time at MDD, here’s a look at the top MDD headlines of each October since 2006.

October 2006 – “Editorial adds to new questions about safety, overuse of DES” and “FDA backs blockbuster tech, but its evaluation continues”

October 2007 – “ICD market gets ‘kick in the shins’ from recall of Medtronic ICD leads”

October 2008 – “Panel eyes election’s impact on future medical innovation”

October 2009 – “Innovation is missing from the healthcare reform debate”

October 2010 – “Medtronic to pay $268M to settle Sprint Fidelis suits” and “New challenges could strain long-standing business model”

October 2011 – “Abbott reports plan to split into two separate companies,” and “HIT seen as hottest investment in healthcare,” “Survey says over 40% of VCs plan to pull back,” and “Can FDA be fixed?”

FacebookTwitterGoogle+Share

Post a Comment

You must be logged in to post a comment.

Register To Comment

Please register to comment on the MDD Perspectives blog. An email will be sent to you with your login and password information. Please store this for future use. Subscribers to the Medical Device Daily publication must also register.

Marketo